8 July 2026 · 5 min read
Who this article is for
Brand owners and category managers reviewing a private-label supplement project.
Vitamin D3 and K2 are often combined in supplements for their synergistic roles in calcium metabolism and bone health. For brand owners, understanding the active forms, typical dosages, and market positioning helps in creating a product that meets consumer demand. This article covers the essential facts to guide your product development, from ingredient sourcing to final labeling, without overstepping regulatory boundaries.
What this active is and typical formats
Vitamin D3 (cholecalciferol) and Vitamin K2 (menaquinone, often MK-7) are fat-soluble vitamins. D3 supports calcium absorption, while K2 directs calcium to bones and teeth. Common formats include softgels, capsules, and liquid drops. Dosages typically range from 1000–5000 IU for D3 and 45–180 mcg for K2, but final amounts depend on the brand's target market and claims.
Category fit for brand ranges
D3+K2 is popular in bone health, immune support, and cardiovascular wellness categories. It appeals to aging consumers, athletes, and those seeking preventive health. The combination is often positioned as a premium daily essential, making it a strong addition to multivitamin lines or standalone offerings. Brands can differentiate through dosage, form (e.g., vegan K2), or added co-nutrients.
Formulation and format considerations
Formulation must account for stability and bioavailability. D3 and K2 are often paired with oils (e.g., MCT) in softgels to enhance absorption. Vegetarian capsules are possible with dry powders but may require careful excipient selection. Taste and texture matter for chewables or gummies. DAT Supply can advise on compatible excipients and manufacturing constraints during the briefing stage.
Compliance and label responsibility
The brand owner is solely responsible for final label claims, regulatory compliance, and market-specific requirements (e.g., health claims, dosage limits). DAT Supply provides raw material documentation but does not approve or guarantee finished product compliance. Brands must verify that their D3 and K2 sources meet local regulations, including any novel food or purity standards.
How to brief this active to DAT Supply
To brief D3+K2, provide target dosage, format preference, capsule size or softgel shape, and any special requirements (e.g., non-GMO, vegan). Indicate desired volume and packaging. DAT Supply uses this brief to propose formulation options and commercial terms. The brand owner should also specify any third-party certifications needed, as these affect sourcing and cost.